{"name":"Laboratoires Thea","slug":"laboratoires-thea","ticker":"","exchange":"","domain":"laboratoiresthea.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Lumigan 0.03% Unit Dose","genericName":"Lumigan 0.03% Unit Dose","slug":"lumigan-0-03-unit-dose","indication":"Other","status":"marketed"},{"name":"Lumigan 0.01%","genericName":"Lumigan 0.01%","slug":"lumigan-0-01","indication":"Other","status":"marketed"},{"name":"Mydriatics","genericName":"Mydriatics","slug":"mydriatics","indication":"Other","status":"phase_3"},{"name":"Prostaglandin","genericName":"Prostaglandin","slug":"prostaglandin","indication":"Other","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"NAABAK eyedrops","genericName":"NAABAK eyedrops","slug":"naabak-eyedrops","indication":"Ophthalmology","status":"marketed"}]}],"pipeline":[{"name":"Lumigan 0.03% Unit Dose","genericName":"Lumigan 0.03% Unit Dose","slug":"lumigan-0-03-unit-dose","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lumigan 0.01%","genericName":"Lumigan 0.01%","slug":"lumigan-0-01","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mydriatics","genericName":"Mydriatics","slug":"mydriatics","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NAABAK eyedrops","genericName":"NAABAK eyedrops","slug":"naabak-eyedrops","phase":"marketed","mechanism":"Ocular inflammation and discomfort","indications":[],"catalyst":""},{"name":"Prostaglandin","genericName":"Prostaglandin","slug":"prostaglandin","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOaXNUT1EzUjBQTGlxZW13UjNQc3ZTeUhDZmdEOXZWQzNWcGtpaWU3RTY4VWxReWlPSUc0Nmx4bUl1bll0enN4V3NybGEybXpKamRqOWdhc0lvRDhwbVdTN3RoSS1LWWpId2p6aVU3UWFUVUhtenl3bHpjZkpkTkZxTHRrcWNHYVhqSHlvNnVXVElqY1h2M1RZbWZtdkd3d2Ix?oc=5","date":"2025-12-03","type":"trial","source":"Fierce Biotech","summary":"Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug - Fierce Biotech","headline":"Théa pens $280M deal for Iolyx's phase 3-ready eye disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQWFhrLWNBSWIzZ1dCVHRuMlZJclY0S3hXaDJLY0hxMTlNRTRmcXFPaFFjSVRYU1BLZ0dRM0t1bjdpQjMyR2k2SGQycTdPQVFXdE5YZzI4dkllaHNhR2E2SHFsbmRWWS1XV3JNT19wamY0YnlDc05BVllaWmJGZ0VMZC0tUDJ3SnhQN2JDUnhoeVNXQ1hjWVZaWjA1Ri1veDBGbmx4OGFHTURyalZ0LUxQeW90bGpJeTZKVmpVcFBGd0gwX2tIMWdDZ1hNbkhOel9hdHc?oc=5","date":"2025-07-08","type":"deal","source":"Ophthalmology Times","summary":"LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada - Ophthalmology Times","headline":"LENZ Therapeutics and Laboratoires Théa partner to commercialize LNZ100 for presbyopia in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxQUjNrbU1ROElYdjg2QWRzeldoUGFlTWpMeXgxWFJWSXNFcGZyQkIxRE5DQk1CTXNJSWhxR0lqWXFZME54NDVXTUlkWXNCZjJaRFBFOE9iTW9nOFczQm1USEdVOUpIT2M0SlNPcThRR25Jd0pRVzgtbGZzZmlQLWtka2hxMjZXN0ZzdzlZSm1qTGFYb0NqTjY5NFUyaXJ5WXRIMmptQzRKVldYNU9BSFd2RXVmNTFfTXpwZ1IxYm5YRUR0TkRnVHU4TFdZaGZSeTdWdkRVN0lsUnZHQkZ6UFBhdWVQZGxXWWZ5ZXZETWZDc2pVbEk3WG9TTE5BZXpxNzF5MEtZWXlhWGFIQQ?oc=5","date":"2025-07-07","type":"deal","source":"LENZ Therapeutics","summary":"LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada - LENZ Therapeutics","headline":"LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPV29QQ2laTkliQVdxbmpDSUJPZ1IzcWVSbmRTX2RveVFIOGdMREhHbXR6aDVzczJMTlo3NnVHRm9mVzU2cEJQb0otSXNIVUtuVG1UOXE2ZFJkUnFKZWVHV1lQbDgzVHVYb01yMFpHcjNPVHFDaVV4UWg4SHR3YlhsNEczdldfX05vU1U4ajVVUlExeVpCdlRWNEJ3RGE3Tnp0cWwyaUZ1ZHhzTk1MTDU2V2pNV2hrbm9OSUN4QVhqZ1N6MW1TdWN4MzllLV8xTjVZS19tcU1sdExfekdMbFNMb3htMXlneHRuOElNWWtRVUtpbDg2SnR3RU1LazZjZw?oc=5","date":"2024-10-02","type":"regulatory","source":"businesswire.com","summary":"Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye - businesswire.com","headline":"Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNR1pWNzVTOFQ3NnpkU1dqOEVXTmRBUjE0cGdUMzdHRnNBLWs0dFowQlVEUS1hd3Bkd2lBbHRlUGxXbWUxX2RBd3lsNTNwNXBPTldGS2RZNjVUYUdHVmNUSnlwSWJwZFl4ZVBSMkYxbkh6a2w3NWprYVE4a1hVdmtHTENpN1lDYU16dUV3eVhicVZLT3dFVjdHMnZtY010Nmt6LUtWcFlLcWcwckh4c0drXzNZazhSNnZFVTJkT2hHdUV4eHZkNEJhTzZqdWFJRGFvTHdYejlORV9aUHZwOWtSODVoOEVCcVRVX1E?oc=5","date":"2023-05-30","type":"pipeline","source":"prnewswire.com","summary":"Thea Pharma Inc. Launches Preservative Freedom Coalition to Advocate for Preservative-free Eye Care - prnewswire.com","headline":"Thea Pharma Inc. Launches Preservative Freedom Coalition to Advocate for Preservative-free Eye Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxOU2lYelpHUW9aS2JPYU5lOFEwcFhmdjBQQnlQZ0dZZnVxRTBwazIwc1ZCWHB4Yl9rdWtCdTdrSHBMMVZRNFZWOEk1TnNhLTlKQWxEVDRlNkI3NWZkb3hyQXdXaGI3c3RUR0ZsNEIyeURKeXUxUXlTT1ZONXlhZlo5U3pNejM5bGNRWld3Z0lpWUVKT2tfTlZHZzlIZExaLVpJYXpUbXU5cy1qUVExd0ZiREtveDFkSmRJMlk1dlNmZi1OdjFaVF84TThtQVJmTF9NeTIwcFkzWkFYLUxVSWd2QkREZFJFOWdaMXNlc3BiV2hVam1jUUJQQWp1QVh5V3RRbWE2Z1YzZ3VxR1N2VVhnaG14cmxDTTFSTURaZDg2RXdmb2d6c3pkeTB3aGpQMzF1S1RHUHI0eC1GQmluZTRDVFVodkFiNHRneFE?oc=5","date":"2023-04-28","type":"patent","source":"prnewswire.com","summary":"Thea Pharma Inc. Statement Related to Akorn's Voluntary Nationwide Recall of Various Human and Animal Drug Branded Ophthalmic Products within Expiry Due to Company Shutdown - prnewswire.com","headline":"Thea Pharma Inc. Statement Related to Akorn's Voluntary Nationwide Recall of Various Human and Animal Drug Branded Ophth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPcGplYy1SbDNlZFRNNmdwaE5meEQtVm5LQVZoei1kbmVQc20yeFQ4NEt6Z3VrOHdNc0FJUG5hQm1kY21TOXd1emxlZ01UOVlfNm5FQ3pEUlA0SWhqUHllUVlmVVViOHNXaE1pUGZ0dkFjWXhESmJGaldhMHVlaS1UT0lRN0NPMDI2WkhiMWZpRWF2ZVQwYldPZ1ZCWDlxWWRMY0hJekhRdTBJZGU4aWJiTmRQZGpPRlM1ME9SZXo0LTRwbzVGOVZxQlp6bw?oc=5","date":"2023-01-10","type":"pipeline","source":"Newswire Canada","summary":"THĒA, EUROPE'S LEADER IN PRESERVATIVE-FREE EYE CARE, LAUNCHES CANADIAN AFFILIATE - Newswire Canada","headline":"THĒA, EUROPE'S LEADER IN PRESERVATIVE-FREE EYE CARE, LAUNCHES CANADIAN AFFILIATE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUGFxLXp2TGJya3NSMkZYUnl2dUhyTnBfUmFiU0psaTNwdkFhVVY0Z0o0enE2REJPTmRPNWZhM19hcVhtakgwQjJNa1h4Z0JHWlcxS0lzMkVULU44RUZnZ00tRVNOU2EzM3NQREx0Y3FZanhFdHB3cnRqeUVrcFM1Q1hIX0pmekhwMy1DTW53STVla0pTRTJTOXRVSFJJandhNnZfS0p0eDZ1MTlOLU1lUm85U1lXVDhEaEFB?oc=5","date":"2022-12-20","type":"regulatory","source":"Fierce Pharma","summary":"Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops - Fierce Pharma","headline":"Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQSGJHVzFPN3FicFNBZHNfNlRoNGF1NlBXUXQxUnpOVlIyVF92UzUtYlhRTF9nY0pzd0hKaFNtUldRaE0yWWJPWk1ySG04TFk3aTJMRUhXakE5T3ZiNUhCNk9qRkpiR1BTWWQ0enpaNXIzLW0xUXI5Y0Uya3E2LTBOMTFGVHJya2M4TEN2OWVXM25NaWd0VmhLSVdtSjdlYWNnZG83Z2g5M0NveHB5ZGRPTFVLM2pOOTU3VTRBcVlNNDRsZG9VSkR4eVo0MjNtYW9rZXdpckxwVlp2MkVSOTRSM1dJaFZpVFY1YkdVYWNWNGw4MFZTcmUtdzJmaTk1aDE4S1BXYjRWX3ctNWhodGJjSFRTWEl4cmVJSXk5YjBqQmRfcUZzN3o5ak44WmtuUE82STlyc0ttME5pYWpp?oc=5","date":"2022-12-15","type":"regulatory","source":"businesswire.com","summary":"Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension - businesswire.com","headline":"Thea Pharma Announces FDA Approval of IYUZEH™ for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQbHh5amlLSEdrUmhvYV95WUdLd3lmNWNlQUozRUJOSmdqeHg5dmphaHJjZVpqdlJ3YUtIUWRvVFBzM1dPNlI4dHY2SjYybm9acDdCRmstakZRUDFNNGdPcGRKX3RwNWtPdi1MVlFUa084SHBDdW5GZk85c2Fjb0pLbzBsRlR1TV9GYTJTV1NzNk5HVExMWFQ0RTAzMzRqUWNhVWxoQkJuUUVvZw?oc=5","date":"2022-06-17","type":"pipeline","source":"imt.ie","summary":"Théa Pharma celebrates new office opening in Castlebar - imt.ie","headline":"Théa Pharma celebrates new office opening in Castlebar","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":3,"phase_3":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}